Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 85
Oncology Drugs 85
Optical 76
Optical Disorders Drugs 75
Immune Disorders Drugs 72
Cardiovascular Drugs 51
Musculoskeletal Disorders Drugs 40
Dermatological Drugs 38
Biopharmaceuticals 36
Biotechnology 31
Genomics 29
Clinical Trials 29
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 23
Skin Cancer Drugs 21
Central Nervous System Drugs 19
Infectious Diseases Drugs 17
Respiratory Drugs 17
Allergy and Immunology 16
Infusions and Injectables 14
Gastrointestinal Drugs 14
Allergy Drugs 14
Drugs by Therapeutic Area 13
Lung Cancer Drugs 11
Dermatology 10
Hematological Drugs 10
Oncology 10
Leukemia Drugs 9
Needles and Syringes 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Diagnostics 7
Biosimilars and Biosuperiors 7
Enzymes 6
Vaccines 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Ovarian Cancer Drugs 5
Transdermal and Transmucosal Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Cardiovascular Devices 4
Drug Delivery 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Proteomics 3
Laboratory Equipment 3
Pediatrics 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Pharmacoeconomics 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Cardiology 2
Endocrinology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

703 Results (Page 22 of 36)
- Relevance
  Sort by

Asthma - Competitive landscape, 2023

 Report
April 2023
240 Pages
Global

From

€3077EUR$3,500USD£2,652GBP

Interleukin Inhibitors - Global Strategic Business Report

 Report
July 2025
288 Pages
Global

From

€5143EUR$5,850USD£4,432GBP

PD-1 and PD-L1 Inhibitors - Global Strategic Business Report

 Report
July 2025
376 Pages
Global

From

€5143EUR$5,850USD£4,432GBP

Antiglaucoma Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Optic Nerve Disorders Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
September 2022
194 Pages
Global

From

€4219EUR$4,799USD£3,636GBP

Ophthalmic Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Panuveitis Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Lung Cancer Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
February 2024
93 Pages
Global

From

€3500EUR$4,264USD£3,121GBP

Anti-Cancer MAbS Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Pediatric Medicines: Global Markets

 Report
November 2019
169 Pages
Global

From

€2418EUR$2,750USD£2,083GBP

Hereditary Orotic Aciduria - Global Strategic Business Report

 Report
July 2025
369 Pages
Global

From

€5143EUR$5,850USD£4,432GBP

Age-Related Macular Degeneration - Global Strategic Business Report

 Report
July 2025
367 Pages
Global

From

€5143EUR$5,850USD£4,432GBP

Leber Congenital Amaurosis - Global Strategic Business Report

 Report
July 2025
402 Pages
Global

From

€5143EUR$5,850USD£4,432GBP

Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human, Humanized, Others), By Application, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
February 2024
260 Pages
Global

From

€2154EUR$2,450USD£1,856GBP

Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029

 Report
January 2025
446 Pages
Global

From

€4352EUR$4,950USD£3,750GBP

Retinal Disorder Treatment - Global Strategic Business Report

 Report
July 2025
375 Pages
Global

From

€5143EUR$5,850USD£4,432GBP

Dermatological Therapeutics Market Analysis & Forecast 2024-2034: Market By Drug Class; By Application; and By Region

 Report
October 2023
145 Pages
Global

From

€2769EUR$3,150USD£2,386GBP

Dilated Cardiomyopathy Therapeutics Market by Therapeutic Class, Treatment Modality, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030

 Report
May 2025
199 Pages
Global

From

€3117EUR$3,545USD£2,686GBP

€3463EUR$3,939USD£2,984GBP

Acute Coronary Syndrome Market by Type, Therapeutic Class, End User, Distribution Channel, Route Of Administration - Global Forecast to 2030

 Report
May 2025
189 Pages
Global

From

€3117EUR$3,545USD£2,686GBP

€3463EUR$3,939USD£2,984GBP

703 Results (Page 22 of 36)
- 1
- 20
- 21
- 22
- 23
- 24

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.